Medicalgorithmics S.A.

Warsaw Stock Exchange MDG.WA

Medicalgorithmics S.A. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD 497.80 K

Medicalgorithmics S.A. Net Cash Used For Investing Activities is USD 497.80 K for the year ending December 31, 2023, a 220.37% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Medicalgorithmics S.A. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -413.57 K, a 89.40% change year over year.
Medicalgorithmics S.A. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -3.90 M, a -191.25% change year over year.
Medicalgorithmics S.A. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -1.34 M, a -82.32% change year over year.
Medicalgorithmics S.A. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -734.95 K, a -214.38% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Warsaw Stock Exchange: MDG.WA

Medicalgorithmics S.A.

CEO	Mr. Maciej Gamrot
IPO Date	Nov. 9, 2011
Location	Poland
Headquarters	Central Tower
Employees	120
Sector	Healthcare
Industries Telehealth Hardware & Electronics Internet of Things (IoT) Medical Instruments Telecommunications & Networking

Description

Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. The company offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and comprehensive reporting; and PocketECG CRS for cardiac rehabilitation monitoring. It also provides ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling single-channel offline monitoring; and PocketECG IV that enables the PocketECG to be connected over the LTE band for continuous ECG signal transmission. In addition, the company offers information technology, biotechnology, ECG monitoring, and scientific research and development services; and manufactures and sells electro-medical equipment. Medicalgorithmics S.A. was founded in 2005 and is headquartered in Warsaw, Poland.

Key trends

Past 5 years